Beam Therapeutics Inc. Common Stock | BEAM

Daily Technical Analysis of Beam Therapeutics Inc. Common Stock

There wasn't too much excitement in Beam Therapeutics today which only managed to move up 0.53% on the day.

Beam Therapeutics doesn't seem to be at a very clear reversal point in either direction. Beam Therapeutics hasn't shown a lot of strength recently, shareholders don't seem that energized about the Biotechnology company's future prospects. BEAM might find some support at the 62.21 level, buyers might push the price back up from here. But it's not very clear what will happen.

Analyst Ratings for Beam Therapeutics By Price Target And Rating

The balance of viewpoints by the analysts is positive. The current Analysts Sentiment Score is 95.19. Most companies range between (-200 to 200).

Here's a break down of the latest rating changes. Wells Fargo & Company dropped their price target by -16% to $105.00 on 2023-03-01. Cantor Fitzgerald announced that they are initiating coverage with a rating of Overweight on 2023-01-31 and they set their price target at $62.00.SVB Leerink dropped their price target by -4.94% to $77.00 on 2023-01-23. BMO Capital Markets upgraded from Market Perform to Outperform on 2022-12-20 and also increased their price target by 8.2% to $66.00. Citigroup initiated a rating of Buy on 2022-12-13 and provided a price target of $62.00. Guggenheim lowered their price target to 102.00 on 2022-11-15. On 2022-11-08 Credit Suisse Group lowered their price target by -18.46% to $53.00. On 2022-08-10 Barclays increased their price target by 57.89% to $60.00. On 2022-08-01 there was confirmation of the previous rating by Wedbush which was Outperform and provided a price target of $100.00. Stifel Nicolaus initiated a rating of Buy on 2021-09-24 and also increased their price target by 41.18% to $120.00.

Earnings Per Share (EPS) Estimates By Year and Quarter

Short interest for Beam Therapeutics

We take into account several different measures of short interest to create a composite score. These measures are shown in the chart below. Short selling is when investors are betting against a stock. We compile these factors to create a dynamic Short Score - this can indicate poor sentiment, internal problems with a company or industry and the anticipation of future price declines. We look at the short interest percent, days to cover, the rate of change and total shares sold short.

Social Sentiment for Beam Therapeutics

Social Sentiment is an aggregation of several different factors such as news, articles, blogs, user content, ratings, etc. Which is shown in the chart below. It may become predictive of a reversal if price and the sentiment diverge. Broader market forces may push prices up or down but if market participants maintain a different view on a specific stock, it may be taken as an opportunity to buy or sell in those cases.